Close Menu

NEW YORK – NanoString Technologies on Monday reported  preliminary first quarter revenue growth of 15 percent and withdrew previously stated full-year financial guidance as a result of the COVID-19 pandemic.

For the quarter ended March 31, NanoString estimated product and service revenue of $24.5 million, slightly short of the firm's prior Q1 guidance of $25 to $28 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports. 

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.